It Will Take More Than Transparency To Reduce Drug Prices, Economists Say
(By Alison Kodjak for NPR) A new drug to treat postpartum depression is likely to reach the U.S. market in
Read More
Part D/Prescription Drugs
Biogen halts studies of closely watched Alzheimer’s drug, a blow to hopes for new treatment
(By Adam Feuerstein for STAT) Alzheimer’s disease has beaten back another effort to tame it. Biogen and its Japanese pharma
Read More“Affordability boards” to review expensive drugs
To rein in prescription drug prices, several states are considering new “affordability boards” to review expensive drugs and if it
Read MoreFentanyl-Linked Deaths: The U.S. Opioid Epidemic’s Third Wave
(By Martha Bebinger for NPR) Men are dying after opioid overdoses at nearly three times the rate of women in
Read MoreBiosimilar approval and adoption in the U.S. needs to be expedited
(By Carlos Sattler and Sheila Frame for STAT) Generic versions of brand-name small-molecule drugs saved Americans more than $1 trillion between 1999
Read MoreWhen medicines are unaffordable, here’s how patients cut costs
(By Megan Thielking for STAT) One in five U.S. adults prescribed medicines say they’ve asked their doctor for a cheaper
Read MoreHow the not-for-profit Civica Rx will disrupt the generic drug industry
(By Marc Harrison for STAT) The generic drug industry should cause prices for medications to drop. But lately it has
Read MoreTime is running out if you want to change your Medicare Advantage plan
Time is running out if you want to change your Medicare Advantage plan or switch back to original Medicare. You
Read MoreFDA approves new generic for valsartan
After multiple recalls of a certain generic valsartan medications, the U.S. Food and Drug Administration has approved a new generic
Read MoreLearning the pluses and minuses to Medicare Advantage plans
Medicare Advantage, also known as Medicare Part C, is one of four parts of the Medicare program. Medicare Part C
Read More